Women's cancer particularities;Particularités du cancer bronchique chez la femme

Revue de Pneumologie Clinique

Volumn 60, Issue 5 III, 2004, Pages

  Quoix, E ^a  

^a Service de Pneumologie Phtisiologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CIGARETTE SMOKING; ENVIRONMENTAL FACTOR; FEMALE; HORMONAL REGULATION; HUMAN; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; PASSIVE SMOKING; PROGNOSIS; REVIEW; RISK FACTOR; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTHROPOMETRY; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MIDDLE AGED; PROGNOSIS; RISK FACTORS; WOMEN'S HEALTH;

EID: 10844249117     PISSN: 07618417     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest 2003;123:21S-49S.
2. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Ann Oncol 2002;13:1087-93.
3. Mennecier B, Lebitasy MP, Moreau L, et al. Women and small cell lung cancer: social characteristics, medical history, management and survival: a retrospective study of all the male and female cases diagnosed in Bas-Rhin (Eastern France) between 1981 and 1994. Lung Cancer 2003;42:141-52.
4. Benhamou E, Benhamou S, Flamant R. Lung cancer and women: results of a French case-control study. Br J Cancer 1987;55:91-5.
5. Ryberg D, Hewer A, Phillips DH, et al. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 1994;54:5801-3.
6. Wei Q, Cheng L, Amos CI, et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 2000;92:1764-72.
7. Mollerup S, Ryberg D, Hewer A, et al. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res 1999;59:3317-20.
8. Kure EH, Ryberg D, Hewer A, et al. p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels. Carcinogenesis 1996;17:2201-5.
9. Nelson HH, Christiani DC, Mark EJ, et al. Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst 1999;91:2032-8.
10. Tseng JE, Rodriguez M, Ro J, et al. Gender differences in p53 mutational status in small cell lung cancer. Cancer Res 1999;59:5666-70.
11. Gealy R, Zhang L, Siegfried JM, et al. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Cancer Epidemiol Biomarkers Prev 1999;8:297-302.
12. Beckett AH, Gorrod JW, Jenner P. The effect of smoking on nicotine metabolism in vivo in man. J Pharm Pharmacol 1971;23:62S-67S.
13. rd. Daily intake of nicotine during cigarette smoking. Clin Pharmacol Ther 1984;35:499-504.
14. Siegfried JM. Women and lung cancer: does oestrogen play a role? Lancet Oncol 2001;2:506-13.
15. Alavanja MC, Brownson RC, Lubin JH, et al. Residential radon exposure and lung cancer among nonsmoking women. J Natl Cancer Inst 1994;86:1829-37.
16. Gao YT, Blot WJ, Zheng W, et al. Lung cancer among Chinese women. Int J Cancer 1987;40:604-9.
17. Cheng YW, Chiou HL, Sheu GT, et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res 2001;61:2799-803.
18. Mayne ST, Buenconsejo J, Janerich DT. Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol 1999;149:13-20.
19. Alavanja MC, Brownson RC, Benichou J, et al. Attributable risk of lung cancer in lifetime nonsmokers and long-term ex-smokers (Missouri, United States). Cancer Causes Control 1995;6:209-16.
20. Alavanja MC, Brownson RC, Boice JD, Jr., et al. Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol 1992;136:623-32.
21. Shriver SP, Bourdeau HA, Gubish CT, et al. Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer. J Natl Cancer Inst 2000;92:24-33.
22. Taioli E, Wynder EL. Re: Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 1994;86:869-70.
23. Charloux A, Quoix E, Wolkove N, et al. The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma. Int J Epidemiol 1997;26:14-23.
24. Blanchon F, Grivaux M, Collon T, et al. [Epidemiologic of primary bronchial carcinoma management in the general French hospital centers]. Rev Mal Respir 2002;19:727-34.
25. de Perrot M, Licker M, Bouchardy C, et al. Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma. J Thorac Cardiovasc Surg 2000;119:21-6.
26. Fry WA, Phillips JL, Menck HR. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer 1999;86:1867-76.
27. Sagman U, Maki E, Evans WK, et al. Small-cell carcinoma of the lung: derivation of a prognostic staging system. J Clin Oncol 1991;9:1639-49.